Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Aquaporin 2 regulation: implications for water balance and polycystic kidney diseases

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Subclassification of diabetes based on quantitative traits

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The role of the complement system in diabetic nephropathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Diabetic nephropathy in 2014: Improved cardiorenal prognosis in diabetic nephropathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Diabetic nephropathy: Could problems with bardoxolone methyl have been predicted?

    Publikation: Bidrag til tidsskriftTidsskriftartikelFormidling

  5. Assessment of kidney function: UACR--two risk markers or a 24 h collection in a minute?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Aquaporin-2 membrane targeting: still a conundrum

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

Targeting the collecting duct water channel aquaporin 2 (AQP2) to the plasma membrane is essential for the maintenance of mammalian water homeostasis. The vasopressin V2 receptor (V2R), which is a GS protein-coupled receptor that increases intracellular cAMP levels, has a major role in this targeting process. Although a rise in cAMP levels and activation of protein kinase A are involved in facilitating the actions of V2R, studies in knockout mice and cell models have suggested that cAMP signalling pathways are not an absolute requirement for V2R-mediated AQP2 trafficking to the plasma membrane. In addition, although AQP2 phosphorylation is a known prerequisite for V2R-mediated plasma membrane targeting, none of the known AQP2 phosphorylation events appears to be rate-limiting in this process, which suggests the involvement of other factors; cytoskeletal remodelling has also been implicated. Notably, several regulatory processes and signalling pathways involved in AQP2 trafficking also have a role in the pathophysiology of autosomal dominant polycystic kidney disease, although the role of AQP2 in cyst progression is unknown. Here, we highlight advances in the field of AQP2 regulation that might be exploited for the treatment of water balance disorders and provide a rationale for targeting these pathways in autosomal dominant polycystic kidney disease.

OriginalsprogEngelsk
TidsskriftNature Reviews Nephrology
Vol/bind17
Udgave nummer11
Sider (fra-til)765-781
Antal sider17
ISSN1759-5061
DOI
StatusUdgivet - nov. 2021

ID: 66565519